HRP20050182A2 - Aqueous 2,6-diisopropylphenol pharmaceutical compositions - Google Patents

Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Info

Publication number
HRP20050182A2
HRP20050182A2 HR20050182A HRP20050182A HRP20050182A2 HR P20050182 A2 HRP20050182 A2 HR P20050182A2 HR 20050182 A HR20050182 A HR 20050182A HR P20050182 A HRP20050182 A HR P20050182A HR P20050182 A2 HRP20050182 A2 HR P20050182A2
Authority
HR
Croatia
Prior art keywords
diisopropylphenol
pharmaceutical compositions
aqueous
propofol
present
Prior art date
Application number
HR20050182A
Other languages
English (en)
Croatian (hr)
Inventor
Zhang Zhong
Almarsson Orn
Chen Hongming
Original Assignee
Transform Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transform Pharmaceuticals filed Critical Transform Pharmaceuticals
Publication of HRP20050182A2 publication Critical patent/HRP20050182A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20050182A 2002-07-29 2003-07-29 Aqueous 2,6-diisopropylphenol pharmaceutical compositions HRP20050182A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US39949002P 2002-07-29 2002-07-29
US42219502P 2002-10-29 2002-10-29
US43697902P 2002-12-30 2002-12-30
US46245003P 2003-04-11 2003-04-11
US46431403P 2003-04-21 2003-04-21
US47040303P 2003-05-14 2003-05-14
US48535403P 2003-07-07 2003-07-07
PCT/US2003/023512 WO2004010941A2 (fr) 2002-07-29 2003-07-29 Compositions pharmaceutiques de 2,6-diisopropylphenol aqueux

Publications (1)

Publication Number Publication Date
HRP20050182A2 true HRP20050182A2 (en) 2006-11-30

Family

ID=31192580

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050182A HRP20050182A2 (en) 2002-07-29 2003-07-29 Aqueous 2,6-diisopropylphenol pharmaceutical compositions

Country Status (14)

Country Link
US (1) US7915317B2 (fr)
EP (1) EP1539122B1 (fr)
JP (3) JP2005538191A (fr)
KR (1) KR101145692B1 (fr)
CN (1) CN100438861C (fr)
AU (1) AU2003261274C1 (fr)
BR (1) BR0313060A (fr)
CA (1) CA2494297C (fr)
HR (1) HRP20050182A2 (fr)
MX (1) MXPA05001061A (fr)
NZ (1) NZ538255A (fr)
PL (1) PL375874A1 (fr)
RS (1) RS54275B1 (fr)
WO (1) WO2004010941A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
WO2004010941A2 (fr) 2002-07-29 2004-02-05 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques de 2,6-diisopropylphenol aqueux
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
WO2004039326A2 (fr) * 2002-10-29 2004-05-13 Transform Pharmaceuticals, Inc. Propofol associe a la cysteine
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
EP3424508B1 (fr) 2004-05-19 2021-05-05 Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Utilisation du désoxycholate de sodium pour l'élimination d'une accumulation localisée de graisse
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
DE102004045622A1 (de) * 2004-09-17 2006-03-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Konservierungsmittel-Zusammensetzungen
WO2007128866A2 (fr) * 2006-05-09 2007-11-15 Novobion Oy Nouvelles compositions chimiques
US8197499B2 (en) * 2006-06-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
CA2656179A1 (fr) * 2006-06-21 2007-12-27 The Board Of Trustees Of The Leland Stanford Junior University Compositions et methodes pour joindre des lumieres non unies
US8608760B2 (en) * 2006-06-21 2013-12-17 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
WO2008092084A2 (fr) 2007-01-26 2008-07-31 Centocor, Inc. Suspension non aqueuse injectable présentant une concentration élevée en agent thérapeutique
US8172861B2 (en) * 2007-12-20 2012-05-08 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
WO2009101263A2 (fr) 2008-02-15 2009-08-20 Novobion Oy Complexes solubles de la curcumine
US8563037B2 (en) * 2009-02-06 2013-10-22 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
MY163215A (en) 2010-04-01 2017-08-30 Pharmanest Ab Thermogelling anaesthetic compositions
US8754125B2 (en) 2010-10-05 2014-06-17 The Medicines Company Antimicrobial preservation of propofol emulsions
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
HUE026295T2 (en) * 2010-10-12 2016-06-28 The Medicines Co Clevidipine emulsion formulations containing antimicrobial agents
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
GB201106031D0 (en) 2011-04-08 2011-05-25 Highway Resource Solutions Ltd Adaptions to a lantern
WO2016061538A1 (fr) 2014-10-16 2016-04-21 The Board Of Trustees Of The Leland Stanford Junior University Nouveaux procédés, composés et compositions d'anesthésie
CN108601732A (zh) * 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法
CN106581737B (zh) * 2017-01-06 2019-09-06 哈尔滨鼓润生物技术有限公司 一种止血组合物及其制备方法
WO2018225229A1 (fr) * 2017-06-08 2018-12-13 Terumo Kabushiki Kaisha Composition aqueuse pharmaceutique parentérale
WO2020206258A1 (fr) * 2019-04-05 2020-10-08 Sorrento Therapeutics, Inc. Compositions pharmaceutiques de cannabidiol
CN114601800B (zh) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 一种甲磷丙泊酚钠无菌粉针剂及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US5296161A (en) * 1986-06-09 1994-03-22 The Clorox Company Enzymatic perhydrolysis system and method of use for bleaching
CN1069741A (zh) * 1991-03-19 1993-03-10 西特克斯公司 具有改进的生物活性的聚氧丙烯/聚氧乙烯共聚物
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5731356A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
AU6708096A (en) 1995-09-18 1997-04-09 Vesifact Ag Propofol nanodispersions
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US20020107291A1 (en) * 1997-05-26 2002-08-08 Vincenzo De Tommaso Clear, injectable formulation of an anesthetic compound
US5962536A (en) * 1998-07-31 1999-10-05 Komer; Gene Injectable propofol formulations
US7097849B2 (en) * 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
US6150423A (en) 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6140373A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
ES2261210T3 (es) * 1999-06-21 2006-11-16 Kuhnil Pharmaceutical Co., Ltd. Comoposicion anestesica para inyeccion intravenosa que comprende propofol.
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
EP1289518A2 (fr) 2000-05-25 2003-03-12 AstraZeneca AB Ameliorations apportees en matiere de survie
AU6689601A (en) * 2000-06-16 2002-01-02 Rtp Pharma Inc Improved injectable dispersions of propofol
IN187686B (fr) 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
IN188917B (fr) 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20030055023A1 (en) 2001-03-20 2003-03-20 Rajewski Roger A. Formulations containing etomidate and a sulfoalkyl ether cyclodextrin
GB0120702D0 (en) 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
GB0124071D0 (en) 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
WO2004010941A2 (fr) 2002-07-29 2004-02-05 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques de 2,6-diisopropylphenol aqueux
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
KR100482269B1 (ko) 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures

Also Published As

Publication number Publication date
AU2003261274A1 (en) 2004-02-16
WO2004010941A3 (fr) 2004-06-17
RS54275B1 (sr) 2016-02-29
KR20050026539A (ko) 2005-03-15
CA2494297A1 (fr) 2004-02-05
MXPA05001061A (es) 2005-10-05
US7915317B2 (en) 2011-03-29
US20050027019A1 (en) 2005-02-03
KR101145692B1 (ko) 2012-05-25
BR0313060A (pt) 2005-06-28
WO2004010941A2 (fr) 2004-02-05
RS20050066A (sr) 2007-09-21
EP1539122B1 (fr) 2014-01-29
EP1539122A2 (fr) 2005-06-15
JP2011144161A (ja) 2011-07-28
EP1539122A4 (fr) 2010-03-10
CA2494297C (fr) 2011-10-18
JP2005538191A (ja) 2005-12-15
AU2003261274B2 (en) 2008-07-31
AU2003261274C1 (en) 2009-02-12
CN1671367A (zh) 2005-09-21
NZ538255A (en) 2006-11-30
JP2014058553A (ja) 2014-04-03
HK1077515A1 (en) 2006-02-17
PL375874A1 (pl) 2005-12-12
CN100438861C (zh) 2008-12-03

Similar Documents

Publication Publication Date Title
HRP20050182A2 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
BR0113912A (pt) Composição tensoativa, e, métodos para preparar uma combinação tensoativa ternária, e para limpar e/ou condicionar o cabelo ou a pele
MEP60808A (en) Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability
BRPI0415449A (pt) combinações de compostos ativos fungicidas sinergìsticos
BRPI0515316A (pt) compostos de imidazoquinolina
MEP35108A (en) Herbicidal composition
MX9306708A (es) Composiciones de espuma de lucha contra el fuego, de un solvente polar de baja viscosidad.
BRPI0412895A (pt) combinações de substáncias ativas fungicidas
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
BRPI0412871A (pt) combinações de substáncias ativas fungicidas
DK1893187T3 (da) Forbedrede antimikrobielle peroxidasepræparater
YU44899A (sh) Pesticidni 1-aril-3-iminopirazoli
UA87627C2 (ru) Фармацевтическая композиция в виде тестостеронового геля и ее использование при лечении гипогонадизма у мужчин
DE69803808D1 (de) Zahnpasta mit hohem feuchtigkeitsgehalt
BR0113463A (pt) Composição farmacêutica para o tratamento e/ou prevenção de infecções clamidiais, composição pró-saúde e seu uso
BR112021025470A2 (pt) Composições intensificadoras de fragrância
BRPI0416787A (pt) composições de limpeza de óleo natural do tipo formadoras de efeito sinalizador "blooming"
BR0208988A (pt) Dentifrìcio herbáceo estável
GT200200249A (es) Composicion herbicida
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
BRPI0512580A (pt) derivados de n-fenilpirazol como pesticidas
BR0313751A (pt) Heterociclilpirimidinas substituìdas
BR0114062A (pt) 2,5-bisaril-delta1-pirrolina opticamente ativas e sua aplicação como composições praguicidas
HRP20080330T3 (en) Antitumoral compounds based on kahalalide f

Legal Events

Date Code Title Description
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060712

Year of fee payment: 4

A1OB Publication of a patent application
OBST Application withdrawn